SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 4, 2026

CSTL

CASTLE BIOSCIENCES INC
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $286K total
Actionable Insight • Neutral

The insider sales are small relative to market cap and follow option exercises, consistent with routine diversification. No bearish signal.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
CSTL ▲ +9.93% at T+20d
NEUTRAL call +9.93% · α vs SPY +10.54% · entry $30.40 → $33.42
Next anchor: T+60d tomorrow
Latest observation: T+56 -22.31% FF3 residual α
Entry = T+0 close
Aug 4, 2026
via day close
T+1d
+0.23%
call +0.23% · α +0.39%
$30.47
settled 3mo ago
T+5d
+3.39%
call +3.39% · α +3.04%
$31.43
settled 3mo ago
T+20d
+9.93%
call +9.93% · α +10.54%
$33.42
settled 8w ago
T+60d
Pending
tomorrow

Price Chart

Loading chart...

Executive Summary

CEO Derek Maetzold and CCO Tobin Juvenal sold a combined ~$286K in open-market sales over a 2-day window (July 31–Aug 3), with Maetzold also exercising options for net-zero-cost shares. The total value is ~0.03% of CSTL's $928M market cap — trivial in proportion. The CEO's sales follow option exercises, consistent with tax-planning or diversification, not a bearish signal. The cluster is small, routine, and non-informative per the asymmetric buy/sell calibration (cluster sells are weak predictors).

Key Financial Metrics

Direction
selling
Total Value
$1.2M
Insiders
2

Key Facts

  • CEO Derek Maetzold sold ~$618K total across July 31 and Aug 3, including shares from option exercises at $0 and $2.39 strike prices
  • CCO Tobin Juvenal sold ~$556K total across July 31 and Aug 3
  • Total open-market sales: ~$1.2M over the 7-day window, ~0.13% of market cap — modest but not material
  • All sales are open-market (code S); option exercises (code M) are non-cash events
  • No insider purchases in the cluster — net direction is selling

Financial Impact

Total insider sales of ~$1.2M represent ~0.13% of CSTL's $928M market cap — modest and routine

dilution

Risk Factors

  • Insider sales could accelerate if the stock rallies further, creating overhead supply
  • No insider buying to signal conviction — all selling direction is a mild negative if fundamentals weaken

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CSTL-1785900947565
31 reports for CSTL
Performance horizon
60% Hit rate @ T+1 6 of 10 directional calls Went positive at some point 9 of 10 best @ T+60▲ +27.32%Mar 5, 2026
Filters
Rows
Reports for CSTL — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
Insider Cluster
NEUTRAL ★ 3/10
$33.19 $33.08▼ −0.33%▲ +0.19%$33.30 (+0.33%)
Oct 5, 2026
21d ago
144
NEUTRAL ★ 4/10
$33.36 $33.00▼ −1.08%▼ −0.84%$33.30 (−0.18%)
Oct 5, 2026
21d ago
Insider Cluster
NEUTRAL ★ 2/10
$33.36 $33.00▼ −1.08%▼ −0.84%$33.30 (−0.18%)
Sep 23, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$35.19 $35.81▼ −1.76%▼ −1.22%$33.30 (+5.37%)
Sep 16, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$36.78 $35.34▼ −3.92%▼ −4.04%$33.30 (−9.46%)
Sep 11, 2026
6w ago
144
NEUTRAL ★ 4/10
$33.44 $35.50▲ +6.16%▲ +6.62%$33.30 (−0.42%)
Sep 3, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$32.91 $32.76▲ +0.46%▼ −0.09%$33.30 (−1.19%)
Sep 2, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$32.65 $32.91▲ +0.80%▲ +1.18%$33.30 (+1.99%)
Sep 1, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$33.42 $32.65▼ −2.30%▼ −3.35%$33.30 (−0.36%)
Aug 27, 2026
8w ago
Insider Cluster
NEUTRAL ★ 4/10
$33.50 $33.03▼ −1.40%▼ −1.10%$33.30 (−0.60%)
Showing 10 of 31

US Market Status

Market Closed — Opens in 5h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 4, 2026